Showing results (1601-1610 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
The Importance of Economic Perspective and Quantitative Approaches in Oncology Value Frameworks of Drug Selection and Shared Decision MakingA Reginald Waldeck, Marc F Botteman, Richard E White, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2017
Letter--The Authors RespondKibum Kim, Robert J DiDomenico, Daniel R Touchette, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2017
Effect of an Advanced Pharmacy Practice Experience on Medication Therapy Management Services in a Centralized Retail Pharmacy ProgramJoseph P Vande Griend, Melissa Rodgers, Wesley NufferJournal of Managed Care & Specialty Pharmacy|April 28, 2017
Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled TrialEylem Ilktac Korcegez, Mesut Sancar, Kutay DemirkanJournal of Managed Care & Specialty Pharmacy|April 28, 2017
Assessment of Clinical Pharmacy Interventions to Reduce Outpatient Use of High-Risk Medications in the ElderlySarah C Weddle, A Shaun Rowe, Julie W Jeter, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2017
Effectiveness of a Clinical Pharmacist Medication Therapy Management Program in Discontinuation of Drugs to Avoid in the ElderlyNicole Caffiero, Thomas Delate, Mercy D Ehizuelen, et al.Journal of Managed Care & Specialty Pharmacy|May 26, 2018
AMCP Partnership Forum: Driving Value and Outcomes in OncologyJournal of Managed Care & Specialty Pharmacy|May 26, 2018
Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival BenefitLisa S Rotenstein, Stacie B Dusetzina, Nancy L KeatingJournal of Managed Care & Specialty Pharmacy|May 26, 2018
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims DataNicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, et al.Journal of Managed Care & Specialty Pharmacy|May 26, 2018
Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer PerspectiveRohit Mistry, Jessica R May, Gaurav Suri, et al.Pageof 186